167 related articles for article (PubMed ID: 37191731)
1. Antibacterial and Antibiofilm Activities of Ceragenins Alone and in Combination with Levofloxacin Against Multidrug Resistant Myroides spp. Clinical Isolates from Patients with Urinary Tract Infections.
Oyardi O; Eltimur T; Demir ES; Alkan B; Savage PB; Akcali A; Bozkurt-Guzel C
Curr Microbiol; 2023 May; 80(6):210. PubMed ID: 37191731
[TBL] [Abstract][Full Text] [Related]
2. A Healthcare-Associated Outbreak of Urinary Tract Infections Due to Myroides odoratimimus.
Kutlu HH; Avcı M; Dal T; Arı O; Durmaz R
Jpn J Infect Dis; 2020 Nov; 73(6):421-426. PubMed ID: 33208588
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Multidrug-Resistant Bacteria, Isolated from Water and Plants in Nigeria, to Ceragenins.
Hashemi MM; Mmuoegbulam AO; Holden BS; Coburn J; Wilson J; Taylor MF; Reiley J; Baradaran D; Stenquist T; Deng S; Savage PB
Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30563216
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ceragenins against Burkholderia cepacia complex.
Demir ES; Oyardi O; Savage PB; Altay HO; Bozkurt-Guzel C
J Antibiot (Tokyo); 2022 Jul; 75(7):403-409. PubMed ID: 35562592
[TBL] [Abstract][Full Text] [Related]
5.
Lorenzin G; Piccinelli G; Carlassara L; Scolari F; Caccuri F; Caruso A; De Francesco MA
Antimicrob Resist Infect Control; 2018; 7():96. PubMed ID: 30094005
[TBL] [Abstract][Full Text] [Related]
6. In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis.
Oyardi Ö; Savage PB; Erturan Z; Bozkurt-Guzel C
J Antimicrob Chemother; 2021 Jan; 76(2):443-450. PubMed ID: 33094334
[TBL] [Abstract][Full Text] [Related]
7. Synergistic efficacy of meropenem, ciprofloxacin and colistin antibiotics against planktonic and biofilm forms of Myroides odoratimimus bacterial isolates.
Taşkın Kafa AH; Hasbek M
Indian J Med Microbiol; 2022; 40(3):399-403. PubMed ID: 35491280
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Ceragenins Alone and in Combinations with Antibiotics Against Multidrug-Resistant Gram Negative Pathogens from Bloodstream Infections.
Yilmaz FN; Öksüz L; Demir ES; Döşler S; Savage PB; Güzel ÇB
Curr Microbiol; 2023 Aug; 80(10):327. PubMed ID: 37620557
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial and Antibiofilm Activities of Ceragenins against
Bozkurt Güzel Ç; Hacioğlu M; Inci G; Savage PB
Turk J Pharm Sci; 2019 Dec; 16(4):444-449. PubMed ID: 32454748
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial Activity of Ceragenins against Vancomycin-Susceptible and -Resistant
Hacioglu M; Yilmaz FN; Oyardi O; Bozkurt Guzel C; Inan N; Savage PB; Dosler S
Pharmaceuticals (Basel); 2023 Nov; 16(12):. PubMed ID: 38139770
[TBL] [Abstract][Full Text] [Related]
11. New Subclass B1 Metallo-β-Lactamase Gene from a Clinical Pathogenic Myroides odoratus Strain.
Xu S; Chen Y; Fu Z; Li Y; Shi G; Xu X; Liu Y; Wang M
Microb Drug Resist; 2018 Sep; 24(7):909-914. PubMed ID: 29227741
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial and antibiofilm activities of ceragenins against
Damar-Çelik D; Mataracı-Kara E; Savage PB; Özbek-Çelik B
J Chemother; 2021 Jul; 33(4):216-227. PubMed ID: 32985386
[TBL] [Abstract][Full Text] [Related]
13. Recurrent Urinary Tract Infection in a Renal Transplant Patient by Pan-resistant Myroides Spp.
Faraz A; Fathima K; Kazmi SY; Al Motery AS; Ghaffar UB; Farhan MA
J Coll Physicians Surg Pak; 2022 Apr; 32(4):S34-S36. PubMed ID: 35633005
[TBL] [Abstract][Full Text] [Related]
14. Comparative In Vitro Activities of First and Second-Generation Ceragenins Alone and in Combination with Antibiotics Against Multidrug-Resistant
Ozbek-Celik B; Damar-Celik D; Mataraci-Kara E; Bozkurt-Guzel C; Savage PB
Antibiotics (Basel); 2019 Aug; 8(3):. PubMed ID: 31461867
[TBL] [Abstract][Full Text] [Related]
15. Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms.
Hashemi MM; Rovig J; Holden BS; Taylor MF; Weber S; Wilson J; Hilton B; Zaugg AL; Ellis SW; Yost CD; Finnegan PM; Kistler CK; Berkow EL; Deng S; Lockhart SR; Peterson M; Savage PB
J Antimicrob Chemother; 2018 Jun; 73(6):1537-1545. PubMed ID: 29635279
[TBL] [Abstract][Full Text] [Related]
16. Use of ceragenins as a potential treatment for urinary tract infections.
Wnorowska U; Piktel E; Durnaś B; Fiedoruk K; Savage PB; Bucki R
BMC Infect Dis; 2019 May; 19(1):369. PubMed ID: 31046689
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus.
Chin JN; Rybak MJ; Cheung CM; Savage PB
Antimicrob Agents Chemother; 2007 Apr; 51(4):1268-73. PubMed ID: 17210765
[TBL] [Abstract][Full Text] [Related]
18. Association of Myroides odoratimimus in immunocompromized piglets with post weaning multisystemic wasting syndrome.
Choudhary M; Choudhary BK; Bera BC; Chaudhari SP; Giri DK; Ghosh RC; Barbuddhe SB
J Appl Microbiol; 2019 Dec; 127(6):1635-1645. PubMed ID: 31517421
[TBL] [Abstract][Full Text] [Related]
19. Activity of levofloxacin and ciprofloxacin against urinary pathogens.
Drago L; De Vecchi E; Mombelli B; Nicola L; Valli M; Gismondo MR
J Antimicrob Chemother; 2001 Jul; 48(1):37-45. PubMed ID: 11418511
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro antimicrobial activities of CSA-142 and CSA-192, second-generation ceragenins, with CSA-13 against various microorganisms.
Bozkurt Guzel C; Oyardi O; B Savage P
J Chemother; 2018; 30(6-8):332-337. PubMed ID: 30663553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
